Canadian medical cannabis patients who kept authorization had better outcomes than unauthorized users
Among 5,433 Canadians using cannabis therapeutically after recreational legalization, those who maintained medical authorization were more likely to use regulated sources, know their dosing, report fewer side effects, and consult healthcare professionals.
Quick Facts
What This Study Found
Authorized patients were more likely to report no side effects (29.9% vs. 23.4%), know their cannabis amounts (32.1% vs. 17.7%), obtain from regulated sources (74.1% vs. 47.5%), and seek info from healthcare professionals (67.8% vs. 48.2%).
Key Numbers
5,433 respondents, 2,941 (54.1%) with authorization. No side effects: 29.9% vs. 23.4% (p<0.001). Knew amount: 32.1% vs. 17.7% (p<0.001). Regulated sources: 74.1% vs. 47.5% (p<0.001). Healthcare professional info: 67.8% vs. 48.2% (p<0.01).
How They Did This
Online survey of 5,433 Canadians using cannabis therapeutically in early 2022 (54.1% held medical authorization). Multivariable logistic regression assessed factors associated with authorization status.
Why This Research Matters
With many patients leaving the medical cannabis system after recreational legalization, this study suggests the medical authorization process provides tangible benefits including better product knowledge, fewer side effects, and professional guidance.
The Bigger Picture
The decline in medical cannabis authorizations post-legalization may mean many therapeutic users are losing the benefits of professional guidance and regulated product access. This has implications for patient safety and health outcomes.
What This Study Doesn't Tell Us
Self-selected survey sample may overrepresent engaged patients. Cross-sectional design cannot determine whether authorization causes better outcomes or whether more health-conscious patients seek authorization. Online survey excludes those without internet access.
Questions This Raises
- ?Should medical cannabis programs be strengthened to retain patients even after recreational legalization?
- ?Would integrating medical cannabis into routine healthcare improve outcomes for unauthorized therapeutic users?
Trust & Context
- Key Stat:
- 74% vs. 48% used regulated sources
- Evidence Grade:
- Large survey with multivariate analysis, but self-selected sample and cross-sectional design limit causal conclusions.
- Study Age:
- 2024 survey of Canadian therapeutic cannabis users in early 2022
- Original Title:
- Canadians' use of cannabis for therapeutic purposes since legalization of recreational cannabis: a cross-sectional analysis by medical authorization status.
- Published In:
- BMC medicine, 22(1), 150 (2024)
- Authors:
- Balneaves, Lynda G(3), Brown, Ashleigh, Green, Matthew, Prosk, Erin, Rapin, Lucile, Monahan-Ellison, Max, McMillan, Eva, Zaid, Jonathan, Dworkind, Michael, Watling, Cody Z
- Database ID:
- RTHC-05108
Evidence Hierarchy
Frequently Asked Questions
Why does medical authorization matter if cannabis is legal recreationally?
This study found authorized patients had fewer side effects, better dosing knowledge, used regulated sources more often, and consulted healthcare providers more frequently, suggesting the medical process provides practical benefits beyond legal access.
Who was more likely to have medical authorization?
Older individuals, those with higher income, and urban residents were more likely to maintain authorization. Those in small towns or rural areas were less likely.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05108APA
Balneaves, Lynda G; Brown, Ashleigh; Green, Matthew; Prosk, Erin; Rapin, Lucile; Monahan-Ellison, Max; McMillan, Eva; Zaid, Jonathan; Dworkind, Michael; Watling, Cody Z. (2024). Canadians' use of cannabis for therapeutic purposes since legalization of recreational cannabis: a cross-sectional analysis by medical authorization status.. BMC medicine, 22(1), 150. https://doi.org/10.1186/s12916-024-03370-7
MLA
Balneaves, Lynda G, et al. "Canadians' use of cannabis for therapeutic purposes since legalization of recreational cannabis: a cross-sectional analysis by medical authorization status.." BMC medicine, 2024. https://doi.org/10.1186/s12916-024-03370-7
RethinkTHC
RethinkTHC Research Database. "Canadians' use of cannabis for therapeutic purposes since le..." RTHC-05108. Retrieved from https://rethinkthc.com/research/balneaves-2024-canadians-use-of-cannabis
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.